- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07594600
The Effect of Low or High Dietary Fiber Diet on Volatile Organic Compounds in Exhaled Breath of Healthy Individuals (FIBRE-MATCH)
Characterization of Fiber-degrading Microbiota in Individuals Without Gastrointestinal Diseases
The aim of this crossover intervention study is to evaluate the volatile organic compounds (VOCs) present in participants at baseline and how these levels change after consuming either a low- or high-dietary fiber diet for three days. This study will involve adults, 18-65 years old, without any gastrointestinal diseases.
The primary objectives are to characterize baseline VOC profiles, assess changes in these profiles after a short-term dietary fiber intervention, determine if specific VOC patterns correlate with dietary fiber intake, and identify the time points at which VOC levels peak. This information will help establish the optimal timing for breath sampling and potentially provide insight into how VOC patterns relate to dietary fiber consumption and degradation.
The expected outcome is that a high-dietary fiber diet will produce a VOC profile enriched in metabolites associated with fiber fermentation compared to a low-dietary fiber diet, and that these VOCs will be consistent with those identified in vitro during fecal fermentation. Each participant will serve as an internal control, enabling within-subject comparisons of VOC levels at baseline and following the dietary fiber intervention.
Participants will receive a whole-food product that is rich in dietary fiber and will consume either a low-fiber diet (10 g/day) or a high-fiber diet (40 g/day) for three days. On the first day of each intervention, participants will also ingest a pH capsule to monitor gastrointestinal pH continuously throughout the three days. After a three-week washout period, participants will cross over to the other intervention arm and undergo another round of gastrointestinal pH monitoring.
In addition to the dietary intervention, participants will complete food and health questionnaires to assess habitual fiber intake and dietary habits. Fecal samples will be collected for in vitro fermentation to functionally profile the gut microbiota by assessing fecal VOCs, short-chain fatty acids (SCFA), and the microbial enzymatic activity and its pH-dependent modulation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Natalie Sundberg PhD Student
- Phone Number: +46 704670585
- Email: natalie.sundberg@oru.se
Study Contact Backup
- Name: Robert Brummer, Professor
- Phone Number: +46 738426600
- Email: Robert.Brummer@oru.se
Study Locations
-
-
-
Örebro, Sweden
- Recruiting
- Örebro University
-
Contact:
- Natalie Sundberg
- Email: fibrematch@oru.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Signed informed consent obtained prior to any study-related procedures.
- Willingness to refrain from regular consumption of prebiotic or probiotic products, as well as medications known to affect gastrointestinal function, for at least four weeks prior to the study visits.
Exclusion Criteria:
- History of complicated gastrointestinal surgery.
- Presence of a gastrointestinal diagnosis or any condition that, in the opinion of the principal investigator, may influence the study outcomes.
- Current diagnosis of a psychiatric disorder.
- Systemic use of antibiotics or steroid medications within the past 3 months.
- Frequent use of NSAIDs (non-steroidal anti-inflammatory drugs) within the 2 months preceding the study visit.
- Regular consumption of prebiotic or probiotic products within the past 4 weeks.
- Alcohol or substance abuse.
- Current smoking or use of nicotine pouches.
- Frequent use of laxatives, antidiarrheal agents, or anticholinergic medications within the 12 weeks preceding the study visit.
- Pregnancy or breastfeeding.
- Respiratory disease or infection.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low Fiber Diet, Then High Fiber Diet
Participants will receive a whole food dietary fiber product to consume 10g of dietary fiber per day over a total of 3 days, equal to a high fiber diet.
After a washout period of 3 weeks, they then receive the same whole food dietary fiber product, to consume 40g of dietary fiber per day in a total of 3 days, equal to a high fiber diet.
|
Dietary Intervention: Low Fiber Diet Whole food dietary fiber product, 10g of dietary fiber consumed per day for 3 days Dietary Intervention: High Fiber Diet Whole food dietary fiber product, 40g of dietary fiber consumed per day for 3 days |
|
Experimental: High Fiber Diet, Then Low Fiber Diet
Participants will receive a whole food dietary fiber product to consume 40g of dietary fiber per day over a total of 3 days, equal to a high fiber diet.
After a washout period of 3 weeks, they then receive the same whole food dietary fiber product, to consume 10g of dietary fiber per day in a total of 3 days, equal to a high fiber diet.
|
Dietary Intervention: High Fiber Diet Whole food dietary fiber product, 40g of dietary fiber consumed per day for 3 days Dietary Intervention: Low Fiber Diet Whole food dietary fiber product, 10g of dietary fiber consumed per day for 3 days |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of a 3-day low fiber diet compared to a 3-day high fiber diet on the Volatile Organic Compound profiles in exhaled breath
Time Frame: 5 weeks
|
Volatile Organic Compound profiles in produced by the 3-day low fiber diet intervention compared to the profiles produced by the 3-day high fiber diet, with a 3-week washout inbetween
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of a low fiber diet on Volatile Organic Compound profiles after 4 hours
Time Frame: 4 hours
|
Volatile organic compound profiles 4 hours after the start of the low fiber diet intervention compared with baseline (0 hours)
|
4 hours
|
|
Effect of a low fiber diet on Volatile Organic Compound profiles after 6 hours
Time Frame: 6 hours
|
Volatile organic compound profiles 6 hours after the start of the low fiber diet intervention compared with baseline (0 hours)
|
6 hours
|
|
Effect of a low fiber diet on Volatile Organic Compound profiles after 8 hours
Time Frame: 8 hours
|
Volatile organic compound profiles 8 hours after the start of the low fiber diet intervention compared with baseline (0 hours)
|
8 hours
|
|
Effect of a high fiber diet on Volatile Organic Compound profiles after 4 hours
Time Frame: 4 hours
|
Volatile organic compound profiles 4 hours after the start of the high fiber diet intervention compared with baseline (0 hours)
|
4 hours
|
|
Effect of a high fiber diet on Volatile Organic Compound profiles after 6 hours
Time Frame: 6 hours
|
Volatile organic compound profiles 6 hours after the start of the high fiber diet intervention compared with baseline (0 hours)
|
6 hours
|
|
Effect of a high fiber diet on Volatile Organic Compound profiles after 8 hours
Time Frame: 8 hours
|
Volatile organic compound profiles 8 hours after the start of the high fiber diet intervention compared with baseline (0 hours)
|
8 hours
|
|
Gastrointestinal pH after a 3-day low fiber diet
Time Frame: 5 weeks
|
Assessment of Gastrointestinal pH measured by the alpHaONE JSPC-1 pH capsule, after a 3-day low fiber diet
|
5 weeks
|
|
Gastrointestinal pH after a 3-day high fiber diet
Time Frame: 5 weeks
|
Assessment of Gastrointestinal pH measured by the alpHaONE JSPC-1 pH capsule, after a 3-day high fiber diet
|
5 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fecal Volatile Organic Compound profiles
Time Frame: 1 week
|
Changes in fecal Volatile Organic Compound profiles produced during fecal fermentation, comparison of baseline (0 hours) profiles with profiles at 24 hours
|
1 week
|
|
SCFA
Time Frame: 1 Week
|
Changes in SCFA levels produced during fecal fermentation, comparison of baseline (0 hours) levels with levels at 24 hours
|
1 Week
|
|
Microbial enzymatic activity
Time Frame: 1 week
|
Changes in microbial enzymatic activity during fecal fermentation, comparison of baseline (0 hours) activity with activity at 24 hours
|
1 week
|
|
Microbiota composition
Time Frame: 1 week
|
Microbiota composition at baseline (0 hours) compared with composition at 24 hours
|
1 week
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Robert Brummer, Professor, Örebro University, Sweden
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2026-00408-01
- 101161484 (Other Grant/Funding Number: European Innovation Council (EIC))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adults
-
Aix Marseille UniversitéNot yet recruitingHealthy Young Adults | Healthy Older AdultsFrance
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingHealthy Adult Participants | Non-smoking, Healthy Adults | Normal Weight AdultsSpain
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Samsung Medical CenterTerminatedHealthy Aging | Healthy AdultsKorea, Republic of
-
King Abdulaziz UniversityUniversity College Dublin; Royal College of Surgeons, IrelandRecruitingHealthy Adults | Healthy NutritionSaudi Arabia
-
Balgrist University HospitalNot yet recruiting
-
Essilor InternationalRecruiting
-
University of PennsylvaniaNational Institute on Aging (NIA)Not yet recruiting
-
MinicircleRecruiting
Clinical Trials on Low, High Fiber Diet
-
Tufts UniversityCompletedSarcopenia | Microbial Colonization | Dietary ExposureUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownObesity | Diabetes Mellitus, Type 2Israel
-
University of Massachusetts, WorcesterAmerican Cancer Society, Inc.Completed
-
Mayo ClinicCompleted
-
University of TorontoCanola Council of CanadaCompleted
-
King Faisal UniversitySaudi Food and Drug AuthorityRecruitingDietary Intervention | Glycemic Response; Satiety | Postprandial Glucose | Fasting, Time RestrictedSaudi Arabia
-
Luxembourg Institute of HealthIntegrated Biobank of Luxembourg; Centre Hospitalier du Luxembourg; Luxembourg...CompletedHealthy Volunteers | Gastrointestinal Microbiome | Dietary FiberLuxembourg
-
Cedars-Sinai Medical CenterRecruitingImplementing a Low Fiber Diet vs. Regular Diet in Postoperative Colorectal Patients With IleostomiesIleostomy; Complications | Bowel Obstruction | Postoperative IleusUnited States
-
Washington University School of MedicineCompletedMicrobiota | Gastrointestinal MicrobiomeUnited States